Sabiedrība ar ierobežotu atbildību "Pharma Manufacture"Active

41503062709Limited liability companyFounded 2012

Key figures

293 636 €+9,0%
Revenue 2025
0100 k200 k300 k’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
050 k100 k’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 17 228 € (81% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~17 228 €
20240 €
20230 €
20220 €
20210 €
20200 €
20190 €
20180 €
20170 €
20160 €
20150 €
20140 €
20130 €
Summary of financial statements2012–2025
20122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets5610514 94619 15819 42653 16735 74458 30628 32238 23039 59031 95152 69881 069
Total non-current assets066289089089089000551155115511551159242924
Total assets5676715 83620 04820 31654 05735 74458 30633 83343 74145 10137 46258 62283 993
Balance sheet — liabilities and equity
Current liabilities0894231 05249 68263 50499 31940 77932 139954625 57034 17736 80837 23256 089
Non-current liabilities00000042 05042 05042 05035 10620 118000
Total liabilities0894231 05249 68263 50499 31982 82974 18951 59660 67654 29536 80837 23256 089
Share capital——————————————
Retained earnings of previous periods——————————————
Profit for the year0-2180-12 121-14 425-13 554-2095-182331 202-18808287741984820 73623 742
Total equity5-2175-15 216-29 634-43 188-45 262-47 085-15 883-17 763-16 935-919465421 39027 904
Income statement
Sales revenue031 94337 48837 76549 91666 87257 592132 07254 218152 924211 369262 979269 476293 636
Operating profit0698-8747-11 026-13 554-2095-182331 202-1880828774111 09820 73628 742
EBITDA0—————————————
Profit before income tax0698-8747-11 026-13 554-2095-182331 202-1880828774111 09820 73628 742
Profit for the reporting year0-2180-12 121-14 425-13 554-2095-182331 202-18808287741984820 73623 742
Labour costs0—————————————
Depreciation of non-current assets0—————————————
Other indicators
Employees13355442388998
Calculated dividend—00000000000017 228

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

100%Sabiedrība ar ierobež…2Gavrilovs Valerijs
CompanyPersonShareholderOther roleAdditional link

Related companies

Summary: Sabiedrība ar ierobežotu atbildību "Pharma Manufacture"

Overview

Sabiedrība ar ierobežotu atbildību "Pharma Manufacture" (reg. no. 41503062709) is a limited liability company. The company was registered in 2012 and has been in the register for 13 years. Registered address: Mārupes nov., Mārupe, "Kargo k-1".

Financial results

Revenue in 2025 was 293 636 €, up 9,0% on the previous year (269 476 €). This is the company's highest revenue among the published years (2012–2025). Net profit for 2025 was 23 742 € (8,1% of revenue). The company was profitable in 6 of the 14 published years. In 2025 the company had 8 employees (9 a year earlier). Revenue per employee was 36 705 €. At the end of 2025, total assets were 83 993 € and equity 27 904 € (33,2% of assets).

Management and owners

The company has one board member. The sole owner of the company is a private individual.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.